Skip to Main Content

Coronavirus disease (COVID-19) and Intellectual Property: Patent Issues

Articles

How Misaligned Incentives Are Now Killing Us
By Gene Quinn and Andrew Berks
How Patent Pooling Can Speed Up a Covid-19 Vaccine
by Ellen t' Hoet
A company that bought Theranos' patents is using them to sue a health startup working on coronavirus tests
By Aaron Holmes
Pharma Companies Pressed To Give Up Patents On Potential COVID-19 Treatments; Gates Foundation, Wellcome To Fund Drug Trials; U.S. Signs Deal With Companies To Produce Potential Vaccines
Collection of news articles
Big drugmakers under pressure to share patents against coronavirus
By Donato Mancini
Blockchain protects IP, tracks tires, supports coronavirus response
By Mark Rockwell and Susan Miller
Berkeley Blockchain Incubator Welcomes Startup Fighting COVID-19
By Samuel Haig
more...less...
The monetization of data is the relevant form of intellectual property here, but it is unclear what kind of IP it currently is. Honestly, it applies to all forms of IP, even trade secrets.
NGOs press drug firm Gilead over potential virus treatment
Volunteers 3D-Print Unobtainable $11,000 Valve For $1 To Keep Covid-19 Patients Alive; Original Manufacturer Threatens To Sue
By Glyn Moody
Facing uproar, patent holder clarifies case against COVID-19 test maker Labrador Diagnostics v. BioFire Diagnostics
Jan Wolf article clarifying the lawsuit
How COVID-19 Could Shake Up Patent Strategies
By Ryan Davis
What If Gov't Allows Patent Infringement For COVID-19 Drugs?
By Matt Rizzolo, Brendan McLaughlin and Ryan Sullivan
How COVID-19 Could Spur The Gov't To Seize Patents
Ryan Davis
Businesses Urged To Make COVID-19 IP Free During Crisis
Britain Eakin
Kappos Says Pandemic Calls For New Medical IP Precedent
Dani Kass
3D Printing As Indirect Patent Infringement Amid COVID-19
By Lucas Osborn
Israel Defies AbbVie IP To Import Generic Drugs For COVID-19
By Dani Kass
Vaccine IP Under Microscope With Coronavirus Outbreak
By Gaby Longsworth and Robert Greene Sterne
The World Needs a Master Plan for Covid-19 Patents. We’re Creating One.
World Intellectual property Organization DG Addresses COVID-19; Statement on Patent Sharing Due this Week
Skilled in the Art: IP Community Braces for Social Distancing + More on the COVID-19 'Patent Troll'
The Global Patent Race for a COVID-19 Vaccine
This is a good description of the patent activity in the field right now
COVID-19 Impacts on Medical Intellectual Property Market Growth Ratio Analysis with Top Players White & Case LLP, Al Tamimi & Company, Quinn Emanuel Urquhart & Sullivan, LLP, WilmerHale, Irell & Manella LLP, Baker McKenzie LLP
Several Law Firms assess the patent landscape
Enterprise Intellectual Property (IP) Management Software Market 2020-2027, Covid-19 Impact | Key Major Players are Anaqua Inc., Patrix AB, IPfolio, SimpleLegal, Pattsy
I included this in 'Patent Issues" because it primarily concerns patents even though all forms of IP are concerned
Canada: Covid-19: Effective Innovation And Patent Management In Crisis Situations Intellectual Property Bulletin
Critically important patent article
Pharmaceutical Patents in the Era of COVID-19: The Aftermath on Developing Countries
By Jobaira Nasrin Khan
COVID-19 IP Catch-Up: USPTO Gets Busy, Zoom Trial Begins
By Dani Kass
more...less...
On changes at the USPTO reflecting a temporary easing of IP restrictions
Australia: Patent Office deadlines and COVID-19
By Madderns Patent & Trade Mark Attorneys
Canada: Patents And Their Role In A COVID-19 Cure
by Melanie Szweras and Carmela De Luca
USPTO Launches ‘Patents 4 Partnerships’ Platform to Fight COVID-19
Says Dr. Anthony Fauci's name appears on "4 U.S. patents for a key glycoprotein” used to “create the current COVID-19 epidemic.”
7 things to know about Gilead, maker of the leading COVID-19 drug
Classified as a "patent issue" because of the content pertaining to the Truvada patent.
Bankruptcy and COVID-19: Issues for Licensors
This is a different kind of IP issue as it relates to peripheral and parallel patent and licensing concerns that don't necessarily directly relate to COVID-19 or its medical treatments
Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19
This concerns an appeal of a revoked patent for a drug that treats psoriasis. The appeal was rescheduled due to the COVID-19 pandemic.
Intellectual Property, Covid-19 and African Countries: better forge your own path?
By Victor Palmela Hidalgo
more...less...
Inventa International is dedicated to legal reform for building innovation ecosystems
USPTO launches COVID-19 Response Resource Center
June 3, 2020
Trump administration narrows search for COVID-19 vaccine to 5 companies
By Noah Weiland and David Sanger
iBio Announces Second COVID-19 Vaccine Program
June 4, 2020
Arbitration of IP Disputes in a Post-COVID-19 World
June 4, 2020
Impact of COVID-19 on Semiconductor (Silicon) Intellectual Property Market: Value Chain, Dynamics and Key Players Faraday Technology, Fujitsu, Mindtree, SoftBank, Synopsys, etc
By pravin@marketinforeports.com
June 4, 2020
more...less...
The byline is answered with an email address(I, Keith Kevelson, assume.) The author does not provide his actual name.
Hackers Target California University Leading Covid Research
By Kartikay Mehrota

June 4, 2020
more...less...
The article was still being updated as of June 7, 2020.
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected
By Chris J. Stewart

June 3, 2020
more...less...
Article is still being updated as of June 7, 2020
Covid-19 Vaccine Funders Urged to Make Drugmakers Share Work
By Matthew Bultman

June 2, 2020
more...less...
This article concerns both patents and trade secrets, and it probably should be labeled under "patent issues," "trade secret issues," and "miscellaneous."
Measures Being Taken by EPO, EUIPO, WIPO and UK IPO in Relation to COVID-19 Pandemic
By J.A. Kemp LLP
June 1, 2020
more...less...
This article probably belongs in multiple categories
How to accelerate your Covid-19 related UK patent application
By Marks & Clerk
June 1, 2020
Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To Win
By Alex Carchidi
June 1, 2020
more...less...
This article really focuses on a company, Vir Biotechnology, that is using a very loose IP-protection strategy.
COVID-19: Upcoming Events & Recorded Webinars
From "Baker McKenzie LLP"

June 1, 2020
more...less...
No byline given, but notice of webinar is from Baker McKenzie
Coronavirus Innovation Guideposts on the Eve of the COVID-19 Pandemic
A National Law Review Article from July 30, 2020 detailing the innovation history on COVID-19 research prior to the pandemic
Moderna reveals it may not hold patent rights for coronavirus vaccine
By Bob Herman
more...less...
This is a MASSIVE legal issue that really shows the immense power and importance of Patent Law
Moderna's Vaccine Technology Continues to be Tangled in Patent Challenges
By Mark Terry
more...less...
Biospace is a well-respected blog for Life Sciences news
WHO embraces plan for Covid-19 intellectual property pool
By Ed Silverman
The Evolution of Antibody Patents
By Karen Carroll and Sharad Bijanki
more...less...
COVID-19 research inherently depends on antibody research
Opinion: Gilead is protecting its drug patent instead of protecting COVID-19 patients
By Rex Nutting
SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review
By José Adão Carvalho Nascimento Junior ORCID Icon, Anamaria Mendonça Santos , Lucindo José Quintans-Júnior ORCID Icon, Cristiani Isabel Banderó Walker , Lysandro Pinto Borges & Mairim Russo Serafini ORCID Icon
A powerful law gives HHS the right to take control of remdesivir manufacturing and distribution
By Christopher Morten, Christian Urrutia, and James Krellenstein
more...less...
This COULD also go into the Licensing Scheme tab, but I think the focus of the article is on the current situation rather than any proposed change.
The Vaccine Scramble Is Also a Scramble for Patents: Intellectual-property disputes throughout the drug supply chain could hold back a Covid-19 shot.
By Cynthia Koons
more...less...
Bloomberg News
Continuing CRISPR Patent Disputes May Be Usurped by Its Potential Role in Fighting Global Pandemics
By Ashwari Churi and Sarah Taylor
PTAB Decides Against Moderna in Challenge to Arbutus Vaccine Patent
By Kim Jordahl
more...less...
This concerns the continuing battle between Moderna and the USPTO that could result in Moderna losing patent rights
PTAB Decides Against Moderna in Challenge to Arbutus Vaccine Patent
By Kim Jordahl
more...less...
On the continuing legal battle between Moderna and the USPTO
Bypass COVID-19 Drug Patents Demand States' Attorney Generals
By Adam Houldsworth
more...less...
This could be considered a compulsory licensing issue as well
How Compulsory Licensing Could Be Used To Combat COVID-19 In The Americas
By: Daphne Laison and Sergio L. Olivares Jr.
more...less...
This could also be tagged under a proposed licensing scheme.
Coronavirus: everyone wins when patents are pooled
By: Nature Editorial Board
WIth Chinese courts back in business, FRAND is on the agenda
By Jacob Schindler
more...less...
A description of Chinese Patent Law issues pertaining to FRAND framework for standards essential patents in the COVID-19 vaccine race
Research and repair: expanding exceptions to patent infringement in response to a pandemic
By Jorge Contreras
Expanding Access to Patents for COVID-19
By Jorge Contreras
PIJIP Supports the Open COVID Pledge
By Jorge Contreras
WHO Recognizes the Open COVID Pledge as a Means to Advance Research and Science in the Fight Against COVID-19
By Diane Peters
Regulations, Voluntary Standards and Social Expectations
By Erika George
more...less...
This is one of the very few talks concerning general IP issues, albeit peripherally, and is only in mp3 audio recording format, not a written article.
Amarin’s terrible year is a cautionary tale for patent litigants
By Adam Houldsworth
Covid-19 shows promise of AI tools – innovators need IP protection, and fast
By Mao Xiao Hong and Danny Yap
more...less...
This article could also be tagged as Miscellaneous as it covers many aspects of IP, but it primarily concerns patents and advocates for relaxing ALICE standards
Japanese covid-19 patent pledge triples membership, but users must read fine print
By Jacob Schindler
Compulsory licensing of COVID-19 treatments unlikely in China, Japan, and South Korea
By He Jing, Lu Yong, Essenese Obhan, Nick Redfearn, Lisa Yong, Toyotaka Abe, Jeong Yeol Choe, Kyung Ae Yoon, Cho Rong Yun, Son Jin
Trade Agency Says Patent Office Takes Lead on Patent Validity
By Matthew Bultman
https://www.uspto.gov/about-us/news-updates/uspto-announces-covid-19-deferred-fee-provisional-patent-application-pilot
An important announcement about USPTO reforms due to COVID-19
Commentary: Race for a COVID-19 vaccine patent could hurt the public
Author: Robert Hu

Last Updated: Aug 28, 2024 6:29 PM
URL: https://law.unh.libguides.com/covidpandemicandintellectualproperty
Print Page

Subjects: Intellectual Property

Tags: coronavirus, COVID-19 IP, novel coronavirus